A NOVEL POINT-OF-CARE REJECTION AND IMMUNOSUPPRESSION MONITORING ASSAY (PRIMA) FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION (VCA)

Wake Forest University Health Sciences, Winston-Salem NC

Investigators